Kuo, Raymond N.
Chen, Wanchi
Shau, Wen-Yi
Funding for this research was provided by:
Pfizer, Taiwan (C4671061, C4671061)
National Science Council grants in Taiwan (110-2410-H-002 -115 -SS3)
Article History
Received: 16 September 2024
Accepted: 30 December 2024
First Online: 26 January 2025
Declarations
:
: This study received approval from the Joint Institutional Review Board of the Medical Research Ethical Foundation, Taipei, Taiwan (approval number No. 23-S-011-1).
: All authors agreed with the publication.
: The authors declare no competing interests.
: Not applicable.
: This study is based on data from the National Health Insurance Research Database provided by the National Health Insurance Administration (NHIA), Ministry of Health and Welfare, and managed by the Health and Welfare Data Science Center (HWDC). The authors do not own the datasets and cannot prevent access to them. Some restrictions apply to the availability of these data, which were used under license for the current study and are not publicly available.
: While preparing this work, the authors used Grammarly © and ChatGPT 4 ONLY for spelling check and editing. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the publication’s content.